homehome
sign up
log in

Legislation from United States of America House of Representatives

Support And Value Expectant Moms and Babies Act of 2019

Track

Give Feedback:

Support

Oppose

Share:

Summary
Title:

Support And Value Expectant Moms and Babies Act of 2019

No summary available.
Actions
09/19/19

Introduced

importance filter:

Introduced in House

Date: September 19, 2019

Content
Code:
116.HR.4399
Subject:
Health
1.Short titleThis Act may be cited as the Support And Value Expectant Moms and Babies Act of 2019 or the SAVE Moms and Babies Act of 2019.
2.Abortion drugs prohibited
  • (a)In generalSection 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) is amended by adding at the end the following:
    • (z)Abortion drugs
      • (1)ProhibitionsThe Secretary shall not approve
        • (A)any application submitted under subsection (b) or (j) for marketing an abortion drug; or
        • (B)grant an investigational use exemption under subsection (i) for
          • (i)an abortion drug; or
          • (ii)any investigation in which the human embryo or human fetus of a woman known to be pregnant is knowingly destroyed.
      • (2)Previously approved abortion drugsIf an approval described in paragraph (1) is in effect for an abortion drug as of the date of enactment of the Support And Value Expectant Moms and Babies Act of 2019, the Secretary shall
        • (A)not approve any labeling change
          • (i)to approve the use of such abortion drug after 70 days gestation; or
          • (ii)to approve the dispensing of such abortion drug by any means other than in-person administration by the prescribing health care practitioner;
        • (B)treat such abortion drug as subject to section 503(b)(1); and
        • (C)require such abortion drug to be subject to a risk evaluation and mitigation strategy under section 5051 that at a minimum
          • (i)requires health care practitioners who prescribe such abortion drug